Quality control method of Reiyanning preparation
The content of single caffeic acid tartaric acid in Reyanning preparations was determined by liquid chromatography, which solved the complex and unstable problems of quality control of Reyanning preparations in the prior art, achieved simplification of operation and improved detection precision, and ensured that Quality control effect of Reyanning preparation.
Patent Information
- Application Number
- CN202411284680.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-07-08
- Filing Date
- 2024-09-13
- Publication Date
- 2024-11-22
AI Technical Summary
The existing quality control methods of Renyanning preparations are complex in operation, have large interference, poor repetition and stability, and require a quality control method with simple operation, small interference, high repetition and high precision.
The content of monocaffeyl tartaric acid in the Renyanning preparation was determined by liquid chromatography for quality control. The dilution step and gradient elution procedure were used to select appropriate chromatographic columns and mobile phase combinations, and the detection conditions were optimized to improve the linear correlation of the detection. degree and stability.
The quality control of Renyanning preparations has been simplified, the detection cost is reduced, the detection cost is improved, the interference is small, durable, linear correlation, repeatability and stability is improved, and the precision and reliability of the detection is ensured.
Smart Images

Figure CN119000952A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of traditional Chinese medicine detection, in particular to a quality control method for a Reyanning preparation. Background Art
[0002] Reyanning is the first-line drug for the clinical treatment of upper respiratory tract infections. It is composed of dandelion, polygonum cuspidatum, Patrinia serrata, and Scutellaria barbata. It has the effects of clearing away heat and detoxifying, promoting blood circulation and removing blood stasis, eliminating carbuncles and dispersing nodules, reducing swelling and relieving pain.
[0003] Monocaffeoyltartaric acid is a phenolic acid compound, also known as caffeoyltartaric acid or caffeoyltartaric acid, with the following structural formula:
[0004]
[0005] Gao Xiaoxia's study "Quality Control Methods of Reyanning and Pharmacokinetic Study of the Index Component Rhein" established the content determination methods of chlorogenic acid and caffeic acid in dandelion, rhein in Polygonum cuspidatum, oleanolic acid in Patrinia patriniae, and baicalin in Scutellaria barbata by high performance liquid chromatography. The extraction process of Reyanning was optimized by orthogonal test. The concentration of extraction solvent ethanol, the amount of extraction solvent, and the number of extractions were optimized by taking the extract yield, chlorogenic acid, caffeic acid, rhein, oleanolic acid, and baicalin content as indicators. Through intuitive analysis, variance analysis, and comprehensive evaluation methods, the optimal extraction process was determined as: adding 10 times 70% ethanol, reflux in a water bath twice, each time for 1 hour, which laid the foundation for the stable quality of Reyanning.
[0006] In the study "Determination of baicalin in Reyanning Granules by HPLC", Liu Kai et al. established a method for determining the content of baicalin in Reyanning Granules by HPLC. Methods Chromatographic column: Ultimate XB-C18 column (4.6×250mm, 5μm); acetonitrile-0.02mol / L potassium dihydrogen phosphate solution (adjusted to pH 5.0 with triethylamine) (14:86) as mobile phase; detection wavelength: 335nm; column temperature: 30℃; flow rate: 1.0mL / min; injection volume: 20μL. Results Baicalin had good linearity in the concentration range of 7.57-30.28mg / L, with an average sample recovery rate of 100.11% and a relative standard deviation of 0.3%.
[0007] The quality control method of Reyanning preparations in the prior art is complicated to operate, has great interference, and has poor repeatability and stability. Therefore, it is necessary to study a quality control method of Reyanning preparations with simple operation, small interference, high repeatability, stability and precision. Summary of the invention
[0008] The purpose of the present invention is to provide a quality control method for a Reyanning preparation. For the drug Reyanning, monocaffeoyltartaric acid is selected for content determination to achieve quality control, and the method has the advantages of high linear correlation, good repeatability and stability, high precision, etc.
[0009] To achieve the above-mentioned purpose of the invention, the technical solution of the present invention is as follows:
[0010] A quality control method for a Reyanning preparation comprises the following steps: determining the content of monocaffeoyltartaric acid in the Reyanning preparation by liquid chromatography to control the quality of the Reyanning preparation.
[0011] Preferably, the minimum content of monocaffeoyltartaric acid is 0.40 mg / mL.
[0012] Preferably, the method for determining the content of monocaffeoyltartaric acid in the Reyanning preparation comprises the following steps:
[0013] (1) preparing a reference solution: diluting monocaffeoyltartaric acid to obtain a reference solution;
[0014] (2) preparing a test solution: the Reyanning preparation is first diluted 5-15 times with solvent 1, and then diluted 5-15 times with solvent 2 to obtain a test solution; the solvent 1 is water, and the solvent 2 is a methanol aqueous solution with a volume fraction of 50-90%;
[0015] (3) Injecting the reference solution and the test solution into a high performance liquid chromatograph to determine the content of monocaffeoyltartaric acid.
[0016] Preferably, in step (1), the monocaffeoyltartaric acid is diluted with a methanol solution, and the concentration of the reference solution is 5-15 μg / mL, for example, 5 μg / mL, 6 μg / mL, 7 μg / mL, 8 μg / mL, 9 μg / mL, 10 μg / mL, 11 μg / mL, 12 μg / mL, 13 μg / mL, 14 μg / mL or 15 μg / mL.
[0017] Further preferably, in step (1), the monocaffeoyltartaric acid is diluted with 40-60% methanol solution, and the concentration of the reference solution is 8-12 μg / mL, for example 8 μg / mL, 9 μg / mL, 10 μg / mL, 11 μg / mL or 12 μg / mL.
[0018] More preferably, in step (1), the monocaffeoyltartaric acid is diluted with a 50% methanol solution, and the concentration of the reference solution is 10 μg / mL.
[0019] Preferably, in step (2), the solvent 2 is a methanol aqueous solution with a volume fraction of 75-90%.
[0020] Preferably, in step (2), the solvent 2 is a methanol aqueous solution with a volume fraction of 75-85%.
[0021] Preferably, in step (2), the solvent 2 is a methanol aqueous solution with a volume fraction of 70-80%.
[0022] Further preferably, in step (2), the solvent is an aqueous methanol solution with a volume fraction of 80%.
[0023] Preferably, in step (2), solvent 1 is diluted 10 times, and then diluted 10 times with solvent 2.
[0024] Preferably, the steps of preparing the test solution are as follows:
[0025] Accurately measure 5 mL of Reyanning preparation, dilute to 50 mL with water, shake well, accurately measure 5 mL, dilute to 50 mL with 80% methanol, shake well, filter through 0.45 μm, take the filtrate to obtain the test solution.
[0026] Preferably, in step (3), the chromatographic conditions are as follows:
[0027] Chromatographic column: chromatographic column with octadecylsilane bonded silica gel as filler;
[0028] Column temperature: 30-40°C;
[0029] Flow rate: 0.6-1.0mL / min;
[0030] Elution program: acetonitrile is used as mobile phase A, 0.15-0.25% phosphoric acid is used as mobile phase B, and the gradient elution program is shown in Table 1:
[0031] Table 1.
[0032] time Mobile phase A Mobile phase B 0min 6-10% 90-94% 30min 9-13% 87-91% 35min 88-92% 8-12% 40min 6-10% 90-94% 45min 6-10% 90-94%
[0033] Detection wavelength: 310-350nm;
[0034] Injection volume: 4-6μL.
[0035] Further preferably, in step (3), the chromatographic column is any one of Agilent 5TC-C18, Agilent ZORBAX SB-C18, Hypersil GOLD, and Welch Ultimate XB-C18.
[0036] Further preferably, in step (3), the column temperature is 34-36°C.
[0037] Further preferably, in step (3), the flow rate is 0.7-0.9 mL / min.
[0038] Further preferably, in step (3), the mobile phase B is 0.2% phosphoric acid.
[0039] Further preferably, in step (3), the gradient elution procedure is as shown in Table 2:
[0040] Table 2.
[0041]
[0042]
[0043] As a specific embodiment of the present invention, the chromatographic conditions are as follows:
[0044] Chromatographic column: Agilent 5TC-C18;
[0045] Column temperature: 35 °C;
[0046] Flow rate: 0.8 mL / min;
[0047] Elution program: acetonitrile as mobile phase A, 0.2% phosphoric acid as mobile phase B, gradient elution program as shown in Table 3:
[0048] Table 3.
[0049] time Mobile phase A Mobile phase B 0min 8% 92% 30min 11% 89% 35min 90% 10% 40min 8% 92% 45min 8% 92%
[0050] Detection wavelength: 330nm;
[0051] Injection volume: 5 μL.
[0052] The beneficial effects of the present invention are:
[0053] The present invention provides a quality control method for a Reyanning preparation, which selects monocaffeoyltartaric acid as the only active ingredient for detection, which not only simplifies the process and reduces the cost, but also has the advantages of small interference, good durability, high linear correlation, good repeatability and stability, and high precision. BRIEF DESCRIPTION OF THE DRAWINGS
[0054] Figure 1 is the solvent chromatogram in Example 1;
[0055] Figure 2 It is the chromatogram of the reference substance in Example 1;
[0056] Figure 3 It is the chromatogram of negative sample in Example 1;
[0057] Figure 4 is the chromatogram of the test product;
[0058] Figure 5 It is the standard curve diagram of Example 1;
[0059] Figure 6 is the linear overlapping chromatogram of Example 1;
[0060] Figure 7 Overlay chromatograms for precision;
[0061] Figure 8 Overlay chromatograms for stability;
[0062] Fig. 9 is a repetitive overlapping chromatogram;
[0063] Fig.10 Overlay chromatograms for recovery;
[0064] Fig.11 Overlapping chromatograms of the two-step dilution method in Example 1, Example 1-a, and Comparative Example 1 of the present invention;
[0065] Fig.12 Detection chromatogram for Comparative Example 2;
[0066] Fig.13 Detection chromatogram for Comparative Example 3;
[0067] Fig.14 Detection chromatogram for Comparative Example 4;
[0068] Fig.15 is the wavelength scanning diagram;
[0069] Fig.16 Examine the overlaid chromatograms for injection volume. DETAILED DESCRIPTION
[0070] The following non-limiting examples can enable those skilled in the art to more fully understand the present invention, but do not limit the present invention in any way. The following content is only an exemplary description of the scope of the present invention, and those skilled in the art can make various changes and modifications to the invention of the present invention based on the disclosed content, and they should also fall within the scope of the present application.
[0071] The present invention is further described below by way of specific examples. The various chemical reagents used in the examples of the present invention are obtained through conventional commercial channels unless otherwise specified. Unless otherwise specified, the contents described below are all weight contents. Unless otherwise specified, it is understood that the process is carried out at room temperature.
[0072] Some experimental materials of the present invention are as follows:
[0073] Agilent 5TC-C18 (4.6mm×250mm, 5μm) chromatographic column, Agilent ZORBAX SB-C18 (250×4.6mm, 5μm) chromatographic column, Hypersil GOLDTM (250×4.6mm, 55μm) chromatographic column, Agilent ECLIPSE XDB-C18 (250×4.6mm, 55μm) chromatographic column; AG285 electronic analytical balance; KQ-500VDE ultrasonic cleaner.
[0074] Reference substance: monocaffeoyltartaric acid (Batch No.: 112087-202101) China Food and Drug Administration
[0075] Yunnan Xinlanjing chromatographic methanol; Yunnan Xinlanjing chromatographic acetonitrile; Tianjin Damao Chemical Reagent Factory chromatographic phosphoric acid; Baishan Wahaha Beverage Co., Ltd. Wahaha drinking purified water; Tianli Chemical Reagent Factory analytical grade methanol; Reyanning is Reyanning mixture, batch numbers: 221107, 221108, 221109, 221117, 221120, 221228, 221229, 221237, 221238, 2301027, 2301028, 2301029, 2311001, 2311002, 2311003, manufacturer: Tsinghua Deren Xi'an Xingfu Pharmaceutical Co., Ltd.
[0076] The embodiment of the present invention provides a quality control method for a Reyanning preparation, comprising the following steps: determining the content of monocaffeoyltartaric acid in the Reyanning preparation by liquid chromatography to control the quality of the Reyanning preparation.
[0077] In some embodiments, the monocaffeoyltartaric acid is present in an amount of at least 0.40 mg / mL.
[0078] In some embodiments, the determination of the content of monocaffeoyltartaric acid in the Reyanning preparation comprises the following steps:
[0079] (1) preparing a reference solution: diluting monocaffeoyltartaric acid to obtain a reference solution;
[0080] (2) preparing a test solution: the Reyanning preparation is first diluted 5-15 times with solvent 1, and then diluted 5-15 times with solvent 2 to obtain a test solution; the solvent 1 is water, and the solvent 2 is a methanol aqueous solution with a volume fraction of 50-90%;
[0081] (3) Injecting the reference solution and the test solution into a high performance liquid chromatograph to determine the content of monocaffeoyltartaric acid.
[0082] In some embodiments, in step (1), the monocaffeoyltartaric acid is diluted with a methanol solution, and the concentration of the reference solution is 5-15 μg / mL, for example, 5 μg / mL, 6 μg / mL, 7 μg / mL, 8 μg / mL, 9 μg / mL, 10 μg / mL, 11 μg / mL, 12 μg / mL, 13 μg / mL, 14 μg / mL or 15 μg / mL.
[0083] In some embodiments, in step (1), the monocaffeoyltartaric acid is diluted with 40-60% methanol solution, and the concentration of the reference solution is 8-12 μg / mL, such as 8 μg / mL, 9 μg / mL, 10 μg / mL, 11 μg / mL or 12 μg / mL.
[0084] In some more preferred embodiments, in step (1), the monocaffeoyltartaric acid is diluted with a 50% methanol solution, and the concentration of the reference solution is 10 μg / mL.
[0085] In some embodiments, in step (2), the Reyanning preparation is first diluted 5 times with solvent 1, and then diluted 5 times with solvent 2 to obtain a test solution;
[0086] In some embodiments, in step (2), the Reyanning preparation is first diluted 10 times with solvent 1, and then diluted 10 times with solvent 2 to obtain a test solution;
[0087] In some embodiments, in step (2), the Reyanning preparation is first diluted 15 times with solvent 1, and then diluted 15 times with solvent 2 to obtain a test solution;
[0088] In some embodiments, the solvent 2 is a methanol aqueous solution with a volume fraction of 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85% or 90%;
[0089] In some embodiments, in step (2), the solvent 2 is a methanol aqueous solution with a volume fraction of 70-80%.
[0090] In some embodiments, in step (3), the chromatographic conditions are as follows:
[0091] Chromatographic column: chromatographic column with octadecylsilane bonded silica gel as filler;
[0092] Column temperature: 35°C; in some embodiments, the column temperature is 30°C, 31°C, 32°C, 33°C, 34°C, 36°C, 37°C, 38°C, 39°C or 40°C.
[0093] Flow rate: 0.6-1.0 mL / min; in some embodiments, the flow rate is 0.6 mL / min; 0.7 mL / min; 0.8 mL / min; 0.9 mL / min; or 1.0 mL / min;
[0094] Elution procedure: acetonitrile as mobile phase A, 0.15-0.25% phosphoric acid as mobile phase B, gradient elution as shown in Table 4:
[0095] Table 4.
[0096] time Mobile phase A Mobile phase B 0min 6-10% 90-94% 30min 9-13% 87-91% 35min 88-92% 8-12% 40min 6-10% 90-94% 45min 6-10% 90-94%
[0097] The detection wavelength is: 330 nm; in some embodiments, the detection wavelength is 310 nm, 315 nm, 320 nm, 325 nm, 328 nm, 332 nm, 335 nm, 340 nm or 350 nm.
[0098] The injection volume is: 5 μL. In some embodiments, the injection volume is 4 μL or 6 μL.
[0099] In some embodiments, in step (3), the chromatographic column is any one of Agilent 5TC-C18, Agilent ZORBAXSB-C18, Hypersil GOLD, and Welch Ultimate XB-C18.
[0100] In some embodiments, in step (3), the mobile phase B is 0.2% phosphoric acid.
[0101] In some embodiments, in step (3), the gradient elution procedure is as shown in Table 5:
[0102] Table 5.
[0103] time Mobile phase A Mobile phase B 0min 8% 92% 30min 11% 89% 35min 90% 10% 40min 8% 92% 45min 8% 92% .
[0104] In order to better illustrate the beneficial effects of the present invention, the technical solutions and beneficial effects of the present invention are further described below through specific embodiments and comparative examples.
[0105] Example 1
[0106] This embodiment provides a quality control method for a Reyanning preparation, comprising the following steps:
[0107] (1) Preparation of reference solution: Take an appropriate amount of monocaffeoyltartaric acid reference substance, accurately weigh it, and add 50% methanol to make a solution containing 10 μg per 1 mL;
[0108] (2) Prepare the test solution: accurately measure 5 mL of Reyanning mixture, place it in a 50 mL volumetric flask, dilute to the mark with water, shake well, accurately measure 5 mL, place it in a 50 mL volumetric flask, dilute to the mark with 80% methanol, shake well, filter through 0.45 μm, and take the filtrate to obtain the solution;
[0109] (3) Accurately pipette 5 μL of the reference solution and the test solution respectively, inject into the liquid chromatograph, and measure. The chromatographic conditions are as follows:
[0110] Chromatographic column: Agilent 5TC-C18;
[0111] Column temperature: 35 °C;
[0112] Flow rate: 0.8 mL / min;
[0113] Elution program: acetonitrile as mobile phase A, 0.2% phosphoric acid as mobile phase B, gradient elution program as shown in Table 6:
[0114] Table 6. Gradient elution program of Example 1
[0115] time Mobile phase A Mobile phase B 0min 8% 92% 30min 11% 89% 35min 90% 10% 40min 8% 92% 45min 8% 92%
[0116] Detection wavelength: 330nm
[0117] Example 1-a, Example 1-b, Example 1-c, Example 1-d, Example 1-e
[0118] Different from Example 1, in Example 1-a, Example 1-b, Example 1-c, Example 1-d, and Example 1-e, only the methanol concentration in step (2) is changed to 50%, 70%, 75%, 85% or 90%, and the other steps are the same. The content determination results are shown in Table 7.
[0119] Comparative Example 1
[0120] The preparation method of the test solution of Comparative Example 1 is:
[0121] Accurately measure 5 mL of Reyanning mixture, place it in a 50 mL volumetric flask, dilute to the mark with water, shake well, accurately measure 5 mL, place it in a 50 mL volumetric flask, dilute to the mark with 20% methanol, shake well, filter through 0.45 μm, and take the filtrate. The other conditions are the same. The results are shown in Table 7 and Fig.11 The content of monocaffeoyltartaric acid measured in Comparative Example 1 is on the low side.
[0122] Table 7. Content determination results of Example 1, Example 1-a, and Comparative Example 1
[0123] sample solvent Content (mg / g) Example 1 80% Methanol 0.555 Example 1-a 50% methanol 0.551 Example 1-b 70% methanol 0.551 Example 1-c 75% Methanol 0.553 Example 1-d 85% Methanol 0.549 Example 1-e 90% Methanol 0.547 Comparative Example 1 20% methanol 0.539
[0124] Comparative Example 2
[0125] Different from Example 1, the test solution preparation method is:
[0126] Accurately measure 2 mL of Reyanning mixture, place it in a 100 mL volumetric flask, add water to the scale, shake well, filter, and the rest remains the same.
[0127] The results are as follows Fig.12 , there are interferences on both sides of the target peak (monocaffeoyltartaric acid).
[0128] Comparative Example 3
[0129] Different from Example 1, the test solution was prepared by directly diluting it with 80% methanol. After shaking Reyanning Mixture (Batch No.: 2301027), 2 mL was accurately measured and placed in a 100 mL volumetric flask. 80% methanol was added to dilute to the scale, shaken, and filtered to obtain the solution. According to the above chromatographic conditions, the injection volume was 10 μL. As a result, more precipitation was produced after adding the solvent, which made filtration more difficult and not conducive to injection.
[0130] Comparative Example 4
[0131] The difference from Example 1 is that the mobile phase A is methanol, the mobile phase B is 0.5% acetic acid, and the rest are the same.
[0132] The results are as follows Fig.13 , the peak shape is poor and there is tailing phenomenon.
[0133] Comparative Example 5
[0134] The difference from Example 1 is that the gradient elution program is shown in Table 8, and the rest is the same:
[0135] Table 8. Comparative Example 2 Gradient Elution Program
[0136] Time (min) A(%) B(%) 0 5 95 5 10 90 40 20 80 55 90 10 56 5 95 60 5 95
[0137] The results are as follows Fig.14 , there are interferences on both sides of the target peak (monocaffeoyltartaric acid).
[0138] Comparative Example 6
[0139] The difference from Example 1 is that the mobile phase B is a 0.3% phosphoric acid aqueous solution, and the rest is the same.
[0140] Comparative Example 7
[0141] The difference from Example 1 is that the mobile phase A is a 0.1% phosphoric acid solution in acetonitrile, and the mobile phase B is a 0.1% phosphoric acid solution in water, and the rest are the same.
[0142] Comparative Example 8
[0143] The difference from Example 1 is that polydatin is used as the content detection target, and the other conditions are the same as those in Example 1.
[0144] Comparative Example 9
[0145] The difference from Example 1 is that emodin is used as the content detection target, and the other conditions are the same as those in Example 1.
[0146] Comparative Example 10
[0147] The difference from Example 1 is that chicoric acid is used as the content detection target, and the other conditions are the same as those in Example 1.
[0148] Test example
[0149] The detection examples of the present invention were tested and investigated from the aspects of the selection of detection wavelength, solvent selection, injection volume, specificity, linear relationship, precision, stability, repeatability, sample recovery rate, durability and detection limit, as shown below.
[0150] 1. Selection of detection wavelength
[0151] Take an appropriate amount of monocaffeoyltartaric acid reference substance, add 50% methanol to prepare a 20 μg / mL reference substance solution, and perform spectral scanning at 200nm-650nm on a UV spectrophotometer. The result shows that monocaffeoyltartaric acid has a maximum absorption near 330nm. Therefore, the test wavelength of the present invention is determined to be 310nm-350nm, and the optimal choice is 330nm. Fig.15 .
[0152] 2. Solvent selection
[0153] According to the scheme in comparative example 2, 2 mL of Reyanning mixture was accurately measured and placed in a 100 mL volumetric flask, water was added to the scale, shaken well, and filtered to obtain the mixture. The rest was the same. Fig.12 , there are interferences on both sides of the target peak (monocaffeoyltartaric acid).
[0154] According to the scheme in Comparative Example 3, the method of directly diluting with 80% methanol is adopted. After taking Reyanning Mixture (Batch No.: 2301027) and shaking it well, 2 mL is accurately measured and placed in a 100 mL volumetric flask, and 80% methanol is added to dilute to the scale, shaken well, and filtered to obtain; according to the above-mentioned chromatographic conditions, the injection volume is 10 μL. As a result, more precipitates are produced after adding the solvent, and filtration is more difficult, which is not conducive to injection.
[0155] Then adopt a two-step dilution method, that is, take Reyanning mixture (batch number: 2301027) and shake it well, then take three samples. For the first sample, according to the scheme of comparative example 1, accurately measure 5mL of Reyanning mixture, put it in a 50mL volumetric flask, dilute it to the scale with water, shake it well, accurately measure 5mL, put it in a 50mL volumetric flask, add 20% methanol to dilute it to the scale, shake it well, filter it, and obtain; for the second sample, according to the scheme in Example 1-a, accurately measure 5mL of this product, put it in a 50mL volumetric flask, dilute it to the scale with water, shake it well, Accurately measure 5mL, place in a 50mL volumetric flask, add 50% methanol to dilute to the scale, shake well, filter, and obtain; for the third sample, according to Example 1, accurately measure 5mL of this product, place in a 50mL volumetric flask, add water to dilute to the scale, shake well, accurately measure 5mL, place in a 50mL volumetric flask, add 80% methanol to dilute to the scale, shake well, filter, and obtain; according to the above-mentioned chromatographic conditions, the injection volume is 10μL, and the results of adding 20% methanol are low, and there is no significant difference in the content determination results of 50% methanol and 80% methanol. It is determined that solvent 2 can use 50%-90% methanol as the solvent, preferably 50%-90% methanol as the solvent, and the optimal is 80% methanol as the solvent. See Table 7, Fig.11 .
[0156] 3. Investigation of injection volume
[0157] Take Reyanning mixture (batch number: 2301027) and shake it well, then accurately measure 5mL of this product, put it in a 50mL volumetric flask, dilute it to the mark with water, shake it well, accurately measure 5mL, put it in a 50mL volumetric flask, dilute it to the mark with 80% methanol, shake it well, filter it, and you have it; according to the chromatographic conditions of the embodiment of the present invention, the injection volumes are 5μL, 10μL and 15μL respectively. As a result, when the injection volume is 5μL, the chromatographic peak separation of the test solution is better. Considering the system error, the injection volume is set to 4-6μL, and the optimal is 5μL. The results are shown in Table 9. Fig.16 .
[0158] Table 9. Results of the injection volume study
[0159]
[0160] 4. Exclusivity
[0161] Take a negative sample without dandelion and Patrinia scabra and prepare it according to the test solution preparation method and measure it according to the chromatographic conditions of Example 1. Figure 1-Figure 4 The negative sample did not show a chromatographic peak at the same retention time as the monocaffeoyltartaric acid reference substance, indicating that the method has good specificity.
[0162] 5. Linear Relationship
[0163] Accurately weigh 10.30 mg of monocaffeoyltartaric acid reference substance (98.3%), place it in a 50 mL volumetric flask, add 50% methanol to dissolve and dilute to the scale, shake well, and use it as the reference substance solution stock solution. Accurately pipette 0.25, 0.5, 1.0, 2.5, 5.0, and 7.5 mL of the reference substance solution stock solution into 10 mL volumetric flasks, add 50% methanol to dissolve and dilute to the scale, shake well, and use it as the reference substance solution. Accurately pipette 5 μL of the above reference substance solution into a liquid chromatograph, and measure according to the chromatographic conditions in Example 1. Use the reference substance solution injection concentration (μg / mL) as the horizontal axis (X) and the peak area (A) as the vertical axis (Y) to draw a standard curve. The results show that the monocaffeoyltartaric acid injection concentration is in a good linear relationship with the peak area in the range of 5.062-151.88 μg / mL; regression equation: Y=23.132X-4.7767; correlation coefficient: R 2 =0.9999. For specific results, see Figure 5-6 And the table below.
[0164] Table 10. Linear relationship determination results
[0165]
[0166]
[0167] 6. Precision test
[0168] Accurately draw the reference solution, operate according to the above chromatographic conditions, repeat the injection 6 times, inject 5 μL each time, measure the peak area and retention time, the RSD% is 0.82% and 0.27%, indicating that the method has good precision. Figure 7 And the table below.
[0169] Table 11. Precision test results
[0170] Injection times Retention time (minutes) Peak area (A) 1 20.542 250.117 2 20.535 250.505 3 20.540 250.953 4 20.757 251.625 5 20.867 251.714 6 20.890 251.639 RSD% 0.82 0.27
[0171] 7. Stability test
[0172] According to the above test sample preparation method, the peak area of the same sample was measured at 0, 4, 8, 12, 36, and 48 hours, and the RSD% was 0.64%, indicating that the sample solution had good stability within 48 hours. Figure 8 And the table below.
[0173] Table 12. Stability test results
[0174]
[0175]
[0176] 8. Repeatability
[0177] According to the test sample preparation method of Example 1, 6 test sample solutions were prepared in parallel for the same batch of samples (batch number: 2301027) and the content was determined. The RSD% was 1.22%, indicating that the method had good repeatability. The results are shown in the following table and Fig. 9 .
[0178] Table 13. Repeatability test results
[0179]
[0180] 9. Sample recovery test
[0181] Using the sample recovery method, accurately weigh 2.5 mL of the same batch of samples with known content (batch number: 2301027), place 6 parallel portions in 50 mL volumetric flasks, accurately add 5 mL of 0.2896 mg / mL monocaffeoyltartaric acid reference solution to each, dilute to the scale with water, shake well, accurately measure 5 mL, place in a 50 mL volumetric flask, add 80% methanol to dilute to the scale, shake well, filter, and obtain.
[0182] According to the above conditions, the average recovery rate is 100.51% and the RSD is 1.27%, which fully meets the standard requirements of "Content of the component to be determined in the sample and the limit of recovery rate" under "9101 Validation of analytical methods" in Part IV of the "Chinese Pharmacopoeia" (2020 edition), that is, when the content of the component to be determined is 1 mg / g, the recovery rate limit is 90%-108%. This shows that the recovery rate is good. The results are shown in the following table and Fig.10 .
[0183]
[0184] Table 14. Results of sample recovery test
[0185]
[0186] 10. Durability
[0187] Column temperature, different chromatographic columns and different models of liquid chromatographs were investigated respectively. The results showed that the method has good durability and can adapt to different column temperatures, different chromatographic columns and different models of liquid chromatographs.
[0188] The specific investigation results are as follows.
[0189] 10.1 Effect of column temperature
[0190] The same sample solution and the same HPLC were used. The column temperature was adjusted to 30℃, 35℃, and 40℃ respectively. Other chromatographic conditions remained unchanged and the results were determined according to the above experimental method. The results showed that the change in column temperature had little effect on the determination results, with an RSD of 0.95%. The ideal separation was achieved and only the retention time was affected. The results are as follows.
[0191] Table 15. Effect of column temperature
[0192] Column temperature Retention time (minutes) Content (mg / mL) 30℃ 23.39 0.549 35℃ 20.91 0.559 40℃ 18.91 0.557 RSD% / 0.95
[0193] 10.2 Investigation of different chromatographic columns and liquid phases
[0194] The chromatographic column selected different chromatographic columns and liquid phases, and the results were all able to achieve satisfactory determination results, with the content RSD being 2.24%, which had little impact on the results. The results are as follows.
[0195] Table 16. Effects of different chromatographic columns and liquid phases
[0196] serial number Liquid Brand Chromatographic column brand Content (mg / g) 1 Agilent1260 Agilent 5TC-C18 0.559 2 Agilent1260 Agilent ZORBAX SB-C18 0.581 3 ThermoFisher U3000 Hypersil GOLD 0.565 4 Hitachi L-2000 Welch Ultimate XB-C18 0.586 RSD% / / 2.24
[0197] 11. Sample content determination
[0198] According to the chromatographic conditions and test sample preparation method of Example 1, 15 batches of sample content were determined, and the results are as follows.
[0199] Table 17. Results of assays of different batches
[0200]
[0201] 12. Limit determination
[0202] After the 15 batches of Reyanning mixture were tested for the content of monocaffeoyltartaric acid according to the above test method and chromatographic conditions, the average content of monocaffeoyltartaric acid was 0.628 mg / mL. Calculated at 70%, the content limit is 0.40 mg / mL. Therefore, the limit of monocaffeoyltartaric acid in Reyanning mixture is determined as "each 1 mL of this product contains dandelion and Patrinia radix as monocaffeoyltartaric acid (C 13 H 12 O9), shall not be less than 0.40 mg. "
[0203] Results Statistics
[0204] According to the detection method in the detection example, the linear correlation coefficient, precision, stability, repeatability, and durability indexes of Example 1, Comparative Example 5, Comparative Example 6, Comparative Example 7, Comparative Example 8, and Comparative Example 9 were detected and counted, and the detection results are shown in Table 18:
[0205] Table 18. Experimental results of Example 1 and Comparative Examples 6-10
[0206]
[0207] The results showed that the change of mobile phase type and concentration had a significant effect on the determination of monocaffeoyltartaric acid in Reyanning mixture. In addition, the selection of active substances also had a significant effect on the detection effect. When the mobile phase or active ingredient was changed, the linear correlation coefficient value decreased, the precision, stability and repeatability decreased, the precision RSD% value increased from 0.27% to 1.0-1.5%, the stability RSD% value increased from 0.64% to 1.6-1.8%, and the repeatability RSD% value increased from 1.22% to 1.5-1.9%.
[0208] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A quality control method for a Reyanning preparation, characterized in that: The following steps are involved: The quality of Reyanning preparation was controlled by determining the content of monocaffeoyltartaric acid in the preparation by liquid chromatography.
2. The quality control method according to claim 1, characterized in that: The minimum content of the monocaffeoyltartaric acid is 0.40 mg / mL.
3. The quality control method according to claim 1, characterized in that: The method for determining the content of monocaffeoyltartaric acid in the Reyanning preparation comprises the following steps: (1) preparing a reference solution: diluting monocaffeoyltartaric acid to obtain a reference solution; (2) preparing a test solution: the Reyanning preparation is first diluted 5-15 times with solvent 1, and then diluted 5-15 times with solvent 2 to obtain a test solution; the solvent 1 is water, and the solvent 2 is a methanol aqueous solution with a volume fraction of 50-90%; (3) Injecting the reference solution and the test solution into a high performance liquid chromatograph to determine the content of monocaffeoyltartaric acid.
4. The quality control method according to claim 3, characterized in that: In step (1), the monocaffeoyltartaric acid is diluted with a methanol solution, and the concentration of the reference solution is 5-15 μg / mL.
5. The quality control method according to claim 4, characterized in that: In step (1), the monocaffeoyltartaric acid is diluted with a 40-60% methanol solution, and the concentration of the reference solution is 8-12 μg / mL.
6. The quality control method according to claim 5, characterized in that: In step (1), the monocaffeoyltartaric acid is diluted with a 50% methanol solution, and the concentration of the reference solution is 10 μg / mL.
7. The quality control method according to claim 3, characterized in that: The steps of preparing the test solution are as follows: Accurately measure 5 mL of Reyanning preparation, dilute to 50 mL with water, shake well, accurately measure 5 mL, dilute to 50 mL with 80% methanol, shake well, filter through 0.45 μm, take the filtrate to obtain the test solution.
8. The quality control method according to claim 3, characterized in that: In step (3), the chromatographic conditions are as follows: Chromatographic column: chromatographic column with octadecylsilane bonded silica gel as filler; Column temperature: 30-40°C; Flow rate: 0.6-1.0mL / min; Elution procedure: acetonitrile as mobile phase A, 0.15-0.25% phosphoric acid as mobile phase B, gradient elution procedure: Detection wavelength: 310-350nm; Injection volume: 4-6μL.
9. The quality control method according to claim 8, characterized in that: The chromatographic column with octadecylsilane bonded silica as filler is any one of Agilent 5TC-C18, Agilent ZORBAX SB-C18, Hypersil GOLD, and Welch Ultimate XB-C18.
10. The quality control method according to claim 3, characterized in that: In step (3), the chromatographic conditions are as follows: Chromatographic column: Agilent 5TC-C18; Column temperature: 35°C; Flow rate: 0.8 mL / min; Elution procedure: acetonitrile as mobile phase A, 0.2% phosphoric acid as mobile phase B, gradient elution procedure: Detection wavelength: 330nm; Injection volume: 5 μL.
